Silvan Tuerkcan Analyst Performance

Analyst at JMP Securities

Silvan Tuerkcan is a stock analyst at JMP Securities in the medical sector, covering 18 publicly traded companies. Over the past year, Silvan Tuerkcan has issued 25 stock ratings, including buy and hold recommendations. While full access to Silvan Tuerkcan's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Silvan Tuerkcan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 47 Last 6 Years
Buy Recommendations: 86.67% 39 Buy Ratings
Companies Covered: 18 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	86.7%	39 ratings
Hold	13.3%	6 ratings
Sell	0.0%	0 ratings

Out of 45 total stock ratings issued by Silvan Tuerkcan at JMP Securities, the majority (86.7%) have been Buy recommendations, followed by 13.3% Hold.

Best & Worst Calls

Best Call
000.0%
TERN
Jun 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
TSHA
Sep 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	77.8% of companies on NASDAQ	14 companies
NYSE	22.2% of companies on NYSE	4 companies

Silvan Tuerkcan, an analyst at JMP Securities, currently covers 18 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 18 companies	100.0%

Silvan Tuerkcan of JMP Securities specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 12 companies	66.7%
PHARMACEUTICAL PREPARATIONS 2 companies	11.1%
MEDICAL INFO SYS 1 company	5.6%
MED - GENERIC DRG 1 company	5.6%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	5.6%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES 1 company	5.6%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
PHR Phreesia	9/8/2025	Boost Price Target	$27.93	$34.00	Market Outperform
EXEL Exelixis	7/29/2025	Reiterated Rating	$37.59	$50.00	Market Outperform
JSPR Jasper Therapeutics	7/8/2025	Lower Price Target	$3.19	$12.00	Market Outperform
CRSP CRISPR Therapeutics	6/27/2025	Reiterated Rating	$46.70	$86.00	Market Outperform
NUVB Nuvation Bio	6/25/2025	Reiterated Rating	$1.99	$6.00	Market Outperform
EXEL Exelixis	6/23/2025	Boost Price Target	$40.37	$50.00	Market Outperform
ELEV Elevation Oncology	6/10/2025	Reiterated Rating	$0.38		Market Perform
SLDB Solid Biosciences	6/6/2025	Reiterated Rating	$4.57	$15.00	Market Outperform
NUVB Nuvation Bio	6/2/2025	Reiterated Rating	$2.31	$6.00	Market Outperform
TSHA Taysha Gene Therapies	5/29/2025	Boost Price Target	$2.82	$6.00	Market Outperform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
CRSP CRISPR Therapeutics	5/21/2025	Reiterated Rating	$39.25	$86.00	Market Outperform
PRME Prime Medicine	5/20/2025	Lower Price Target	$1.26	$6.00	Market Outperform
FHTX Foghorn Therapeutics	5/15/2025	Reiterated Rating	$4.18	$9.00	Market Outperform
BNTC Benitec Biopharma	5/15/2025	Reiterated Rating	$13.30	$20.00	Market Outperform
VOR Vor Biopharma	5/9/2025	Reiterated Rating	$0.14	$6.00	Market Perform
FHTX Foghorn Therapeutics	4/30/2025	Reiterated Rating	$4.16	$9.00	Market Outperform
TSHA Taysha Gene Therapies	4/28/2025	Reiterated Rating	$1.84	$5.00	Market Outperform
FHTX Foghorn Therapeutics	4/23/2025	Initiated Coverage	$4.24	$9.00	Market Outperform
NUVB Nuvation Bio	4/23/2025	Initiated Coverage	$2.07	$6.00	Market Outperform
TERN Terns Pharmaceuticals	4/21/2025	Reiterated Rating	$2.80	$20.00	Market Outperform
EXEL Exelixis	4/17/2025	Reiterated Rating	$36.30	$41.00	Market Outperform
BNTC Benitec Biopharma	4/10/2025	Boost Price Target	$11.64	$20.00	Market Outperform
CRSP CRISPR Therapeutics	2/13/2025	Reiterated Rating	$42.61	$86.00	Market Outperform
EXEL Exelixis	1/23/2025	Reiterated Rating	$32.70	$41.00	Market Outperform
EXEL Exelixis	1/15/2025	Boost Price Target	$36.78	$41.00	Market Outperform

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.